ACHM30 AtriClip FLEX-Mini LAA Exclusion System
AtriCure, Inc. · Decision date Oct 21, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 10/21/2026 for K263319, the ACHM30 AtriClip FLEX-Mini LAA Exclusion System, submitted by AtriCure, Inc. of Mason, Ohio. The application was received 09/21/2026 and reviewed under regulation 878.4300, classification name Left Atrial Appendage Clip, Implantable, with product code PZX and subsequent product code FZX. The regulation medical specialty is listed as General & Plastic Surgery, and the review panel as Cardiovascular. SESE denotes 510(k) clearance, not premarket approval.
The record describes the submission type as Special, with no third-party review, no combination product status and no authorized predetermined change control plan. The page does not state which components or modifications distinguish this device from its predicate, nor does it include a summary statement, so the basis for the equivalence finding and any labeling or indication details remain unknown from this source.
The listed decision date is 10/21/2026, and the page shows a last-updated date of 10/26/2026. No clinical, efficacy or patient-selection conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263319
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- AtriCure, Inc.
- Product code
- PZX
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Left Atrial Appendage Clip, Implantable.
- Applicant
- AtriCure, Inc.
- Product code
- PZX
- FDA device class
- 2
FDA decision timeline
K263319 received
Application receipt date recorded by FDA.
K263319 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
AtriCure, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Mason, OH
Sources and methodology
- Original FDA record: K263319
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records